ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY

被引：1207

作者：

BLUM, RH ^{[1
]}

CARTER, SK ^{[1
]}

机构：

[1] NCI, DIV CANC TREATMENT, BETHESDA, MD 20014 USA

来源：

关键词：

D O I：

10.7326/0003-4819-80-2-249

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：249 / 259

页数：11

共 71 条

[1] [Anonymous], [No title captured]
[2] Arcamone F., 1972, INT S ADRIAMYCIN, P9, DOI [10.1007/978-3-642-95227-2_2, DOI 10.1007/978-3-642-95227-2_2]
[3] ARENA E, 1971, ARZNEI-FORSCHUNG, V21, P1258
[4] BACHUR N, 1973, P AM ASSOC CANC RES, V14, P56
[5] BACHUR NR, 1971, P AM ASSOC CANC RES, V12, P33
[6] BENJAMIN RS, 1973, CANCER CHEMOTH REP 1, V57, P98
[7] BENJAMIN RS, 1972, 14 INT C HEM SAO PAU
[8] HEXAMETHYLMELAMINE - NEW DRUG WITH ACTIVITY IN SOLID TUMORS
BLUM, RH
LIVINGSTON, RB
CARTER, SK
[J]. EUROPEAN JOURNAL OF CANCER, 1973, 9 (03) : 195 - 202
[9] BLUM RH, 1973, CANCER, V31, P903, DOI 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO
[10] 2-N